Literature DB >> 11689237

Investigation of the distribution and excretion of okadaic acid in mice using immunostaining method.

Emiko Ito1, Takeshi Yasumoto, Akira Takai, Susumu Imanishi, Kenichi Harada.   

Abstract

This paper describes the distribution and excretion of okadaic acid (OA) administered orally to mice and examined by immunostaining method. Five min after administration, OA was systemically distributed, being detected in the lung, liver, heart, kidney, and small and large intestine. The swollen small intestinal villi contained OA, causing the separation of epithelial cells from villi and erosion, which developed within 1h. Bleeding and edema in the lung were also found, and the distribution of OA coincided with these injuries. Although a considerable amount of OA was accumulated in the liver, no symptoms, such as bleeding, were observed. The detection of OA continued for 2 weeks in the liver and blood vessels. Excretion from kidney, cecum and large intestine began even after 5 min of the administration, and the excretion from intestine continued for 4 weeks.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11689237     DOI: 10.1016/s0041-0101(01)00207-0

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  14 in total

1.  Multi-omics analysis reveals metabolism of okadaic acid in gut lumen of rat.

Authors:  Yang Liu; Yang Lu; Yu-Hu Jiao; Da-Wei Li; Hong-Ye Li; Wei-Dong Yang
Journal:  Arch Toxicol       Date:  2022-01-16       Impact factor: 5.153

Review 2.  Targets and effects of yessotoxin, okadaic acid and palytoxin: a differential review.

Authors:  Antonella Franchini; Davide Malagoli; Enzo Ottaviani
Journal:  Mar Drugs       Date:  2010-03-16       Impact factor: 5.118

3.  The algal hepatoxoxin okadaic acid is a substrate for human cytochromes CYP3A4 and CYP3A5.

Authors:  Fujiang Guo; Tianying An; Kathleen S Rein
Journal:  Toxicon       Date:  2009-08-20       Impact factor: 3.033

4.  GENE EXPRESSION PROFILING OF HUMAN LIVER CARCINOMA (HepG2) CELLS EXPOSED TO THE MARINE TOXIN OKADAIC ACID.

Authors:  Lynne A Fieber; Justin B Greer; Fujiang Guo; Douglas C Crawford; Kathleen S Rein
Journal:  Toxicol Environ Chem       Date:  2012-10-10       Impact factor: 1.437

5.  Okadaic acid toxin at sublethal dose produced cell proliferation in gastric and colon epithelial cell lines.

Authors:  Miguel del Campo; Héctor Toledo; Néstor Lagos
Journal:  Mar Drugs       Date:  2013-12-02       Impact factor: 5.118

6.  Experimental basis for the high oral toxicity of dinophysistoxin 1: a comparative study of DSP.

Authors:  Diego A Fernández; M Carmen Louzao; María Fraga; Natalia Vilariño; Mercedes R Vieytes; Luis M Botana
Journal:  Toxins (Basel)       Date:  2014-01-03       Impact factor: 4.546

Review 7.  Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?

Authors:  Rex Munday
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

Review 8.  Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration.

Authors:  Miguel Medina; Jesús Avila; Nieves Villanueva
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

9.  Oral toxicity of okadaic acid in mice: study of lethality, organ damage, distribution and effects on detoxifying gene expression.

Authors:  Andres C Vieira; Juan A Rubiolo; Henar López-Alonso; José Manuel Cifuentes; Amparo Alfonso; Roberto Bermúdez; Paz Otero; Mercedes R Vieytes; Félix V Vega; Luis M Botana
Journal:  Toxins (Basel)       Date:  2013-11-08       Impact factor: 4.546

Review 10.  Risk assessment of shellfish toxins.

Authors:  Rex Munday; John Reeve
Journal:  Toxins (Basel)       Date:  2013-11-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.